| During the early
years of HIV -- 1980 to 1985 -- methamphetamine was not implicated with
HIV.
From 1985 until
1996, PWAs were using
low doses of crystal meth because it made them feel better, what they
didn't know was that crystal meth was keeping them alive.
The success of HIV cocktails from
1996 to 2000 led to a widespread movement in the medical community against
meth use.
In 2000, that movement began to fork in
two directions among the medical community.
By 2001,
other nations throughout the world were turning to harm reduction for the
answers; the US maintained its zero tolerance policy.
From 2002 until
2005, the medical community was doing everything it possibly could
to convince the public that methamphetamine was linked to the transmission
of HIV. In 2005,
Senators Feinstein and Harkins introduced the Methamphetamine Control Act
& quality of crystal methamphetamine drops. Meanwhile, Terry
Jernigan's paper, Effects of Methamphetamine Dependence & HIV
Infection on Cerebral Morphology (left panel) sparks reaction
after volume increases of basal ganglia and the parietal
cortex "surprise" research.
In 2007,
research is in limbo, leaving the medical community divided; medical opinions and causing conflict
among HIV healthcare providers. |